未登录

刘彬 (Bin Liu)

seventh medical center of chinese pla general hospital教授

H指数:22

被引数:1,769

个人简介

"基本信息姓名刘彬性别男学历博士职称教授电子邮件Liubin1@ctgu.edu.cn导师类别硕士生导师研究方向、主要学术成就及学术兼职等刘彬，教授、国家和湖北省海外青年人才、德国洪堡学者、硕士生导师，主要从事基于动态共价键的可控超分子组装，大π共轭体系（富勒烯、纳米石墨烯、卟啉和异卟啉等）的合成、结构与性质研究。在Nat. Chem.、J. Am. Chem. Soc.、 Angew. Chem. Int. Ed.等国际知名期刊发表论文30余篇。课题组长期招聘有机框架材料、..."

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

国家和湖北省海外青年人才
德国洪堡学者

Prime assembly with linear DNA donors enables large genomic insertions

线性DNA供体介导的质粒组装实现大规模基因组插入

IF48.5

2026-04-290

PRE

Impact of advanced paternal age on reproductive outcomes in preimplantation genetic testing cycles of young female: a retrospective cohort study

高龄男性对年轻女性胚胎植入前遗传学检测周期中生殖结局的影响：一项回顾性队列研究

Frontiers in Reproductive Health

IF2.9

2026-01-230

OAAI

Triclocarban impacts human sperm motility by inhibiting glycolysis and oxidative phosphorylation

Triclocarban通过抑制糖酵解和氧化磷酸化影响人类精子活力

ASIAN JOURNAL OF ANDROLOGY

IF2.7

2025-09-010

PRE

Targeted therapy of non-small cell lung cancer: mechanisms and clinical trials

FRONTIERS IN ONCOLOGY

IF3.3

2024-09-265

OAAI

PH009-1, a highly potent, selective and brain-penetrable fourth-generation EGFRTKI that overcome classic and resistant EGFR mutations in NSCLC

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Discovery of YK-029A, a novel mutant EGFR inhibitor targeting both T790 M and exon 20 insertion mutations, as a treatment for NSCLC

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2023-10-017

PRE

Targeted genome editing with a DNA-dependent DNA polymerase and exogenous DNA-containing templates

使用DNA依赖性DNA聚合酶和含外源DNA的模板进行靶向基因组编辑

NATURE BIOTECHNOLOGY

IF41.7

2023-09-1414

PRE

Template-jumping prime editing enables large insertion and exon rewriting in vivo

模板跳跃素数编辑可实现体内大插入和外显子重写

NATURE COMMUNICATIONS

IF15.7

2023-06-0817

OAAI

PH009-1, a highly potent and selective fourth-generation EGFR-TKI overcoming EGFR common mutations and T790M/C797S-mediated resistance in NSCLC

CANCER RESEARCH

IF16.6

2023-04-041

PRE

Molecular pathways, resistance mechanisms and targeted interventions in non-small-cell lung cancer

非小细胞肺癌的分子通路、耐药机制及靶向干预

MOLECULAR BIOMEDICINE

IF10.1

2022-12-1226

OA

CRISPR/CAS9: A promising approach for the research and treatment of cardiovascular diseases

CRISPR/CAS9: 一种研究和治疗心血管疾病的有前途的方法

PHARMACOLOGICAL RESEARCH

IF10.5

2022-11-019

PRE

A split prime editor with untethered reverse transcriptase and circular RNA template

具有不受限制的逆转录酶和环状RNA模板的分裂素数编辑器

NATURE BIOTECHNOLOGY

IF41.7

2022-04-0495

PRE

Modulating CRISPR/Cas9 genome-editing activity by small molecules

通过小分子调节CRISPR/Cas9基因组编辑活性

DRUG DISCOVERY TODAY

IF7.5

2022-04-0117

PRE

A flexible split prime editor using truncated reverse transcriptase improves dual-AAV delivery in mouse liver

MOLECULAR THERAPY

IF12

2022-03-0173

OAAI

D-dopachrome tautomerase contributes to lung epithelial repair via ACKR3-dependent Akt signaling

EUROPEAN RESPIRATORY JOURNAL

IF21

2021-11-250

PRE

D-dopachrome tautomerase contributes to lung epithelial repair via atypical chemokine receptor 3-dependent Akt signaling

IF10.8

2021-06-0124

OAAI

Two Sides of the Same Coin: Emergence of Foldamers and Self-Replicators from Dynamic Combinatorial Libraries

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2021-05-0618

OAAI

Self-Sorting in Dynamic Combinatorial Libraries Leads to the Co-Existence of Foldamers and Self-Replicators

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

IF16.9

2021-05-0514

OAAI

Efficacy and long-term safety of CRISPR/Cas9 genome editing in the SOD1-linked mouse models of ALS

COMMUNICATIONS BIOLOGY

IF5.1

2021-03-2538

OAAI

Transcriptional activation of cyclin D1 via HER2/HER3 contributes to EGFR-TKI resistance in lung cancer

通过HER2/HER3转录激活细胞周期蛋白D1在肺癌egfr-tki耐药中的作用

BIOCHEMICAL PHARMACOLOGY

IF5.6

2020-08-0113

OAAI